Canada Drug Approvals
Health Canada approves a drug by issuing a Notice of Compliance. This is every new drug it has approved since 1994, and for each new active substance, how long after the US it came.
7,540 new drug approvals from Health Canada since 1994, 1,047 of them new active substances. Each new substance is matched to its first US approval, so you can see how far Canada runs behind.
- New substances, last 12 months: 47
- Approved in the US first, last 5 years: 68%
- Median lag when US first: 18 months
- Approved with conditions, last 5 years: 25
New Active Substances per Year
Approved by Health Canada, 2005 to Nov 13, 2026.
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
- Full year
- 2026 to date
Months Behind the US
Median, for new substances the US approved first, by year of Canadian approval.
How to read this
A hatched bar is a year that is not over, so its count covers only part of the year.
- Full year
- 2026 to date
Most New Substances
Sponsors, 2022 to 2026.
- Astrazeneca Canada Inc12
- Pfizer Canada ULC9
- Merck Canada Inc8
- Eli Lilly Canada Inc7
- Janssen Inc7
- Glaxosmithkline Inc6
- Moderna Biopharma Canada Corporation5
- Bayer Inc5
- Novartis Pharmaceuticals Canada Inc5
- Abbvie Corporation5
Newest Approvals
New drug submissions approved in the last two years; each drug opens Health Canada's notice| Nov 13, 2026 | FoundayoOrforglipron calcium | Eli Lilly Canada Inc | New substance | — |
| Nov 10, 2026 | YondelisTrabectedin | Xediton Pharmaceuticals Inc | New submission | — |
| Nov 10, 2026 | InpefaSotagliflozin | Bgp Pharma ULC | New substance | — |
| Nov 10, 2026 | InluriyoImlunestrant tosylate | Eli Lilly Canada Inc | New substance | — |
| Nov 9, 2026 | OptisonPerflutren protein-type a microspheres | Ge Healthcare Canada Inc | New submission | — |
| Nov 4, 2026 | McofluInfluenza A/H1N1 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza A/H3N2 mrna,… | Moderna Biopharma Canada Corporation | New substance | — |
| Nov 4, 2026 | MflusivaInfluenza A/H1N1 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza A/H3N2 mrna,… | Moderna Biopharma Canada Corporation | New substance | — |
| Oct 30, 2026 | HibsagoBepirovirsen sodium | Glaxosmithkline Inc | New substance, priority | — |
| Oct 29, 2026 | Apo-DextroamphetamineDextroamphetamine sulfate | Apotex Inc | New submission | — |
| Oct 29, 2026 | OnstryvSafinamide mesylate | Xediton Pharmaceuticals Inc | New submission | — |
| Oct 23, 2026 | MifisoMifepristone / Misoprostol | Nordic Group B.V. | New submission | — |
| Oct 20, 2026 | MifegymisoMifepristone / Misoprostol | Nordic Group B.V. | New submission | — |
| Oct 19, 2026 | Tudorza GenuairAclidinium bromide | Azurity Pharmaceuticals Ireland Limited | New submission | — |
| Oct 15, 2026 | Allegra-DFexofenadine hydrochloride / Pseudoephedrine hcl | Opella Canada Inc. | New submission | — |
| Oct 15, 2026 | Bisoprolol TabletsBisoprolol fumarate | Sanis Health Inc | New submission | — |
| Oct 14, 2026 | MyqorzoAficamten | Cytokinetics, Incorporated | New substance | — |
| Oct 9, 2026 | Neuraxpharm-ModafinilModafinil | Neuraxpharm Pharmaceuticals, S.L. | New submission | — |
| Oct 9, 2026 | Pms-LoxapineLoxapine succinate | Pharmascience Inc | New submission | — |
| Oct 8, 2026 | Oczyesa XrOctreotide hydrochloride | Camurus AB | New submission | — |
| Oct 8, 2026 | JascaydNerandomilast | Boehringer Ingelheim (Canada) Ltd Ltee | New substance | — |
| Oct 7, 2026 | Duaklir GenuairAclidinium bromide / Formoterol fumarate dihydrate | Azurity Pharmaceuticals Ireland Limited | New submission | — |
| Oct 7, 2026 | CaprelsaVandetanib | Esteve Pharmaceuticals S.A. | New submission | — |
| Oct 2, 2026 | FrehemgoDenecimig | Novo Nordisk Canada Inc | New substance | — |
| Oct 2, 2026 | AllegraFexofenadine hydrochloride | Opella Canada Inc. | New submission | — |
| Sep 29, 2026 | TlandoTestosterone undecanoate | Verity Pharmaceuticals Inc | New submission | — |
| Sep 28, 2026 | DawnzeraDonidalorsen sodium | Celystra Pharma Inc. | New substance | — |
| Sep 25, 2026 | ZolymbusBimatoprost | Laboratoires Thea | New submission | — |
| Sep 25, 2026 | SibboranLandiolol hydrochloride | Aop Orphan Pharmaceuticals GmbH | New submission | — |
| Sep 24, 2026 | Aa-SucralfateSucralfate | Aa Pharma Inc | New submission | — |
| Sep 24, 2026 | Prostalumin(18F)PSMA-1007 | Centre For Probe Development And Commercialization | New substance | — |
| Sep 24, 2026 | HernexeosZongertinib | Boehringer Ingelheim (Canada) Ltd Ltee | New substance | With conditions |
| Sep 18, 2026 | Riva-IsavuconazoleIsavuconazonium sulfate | Laboratoire Riva Inc | New submission | — |
| Sep 16, 2026 | Apo-NorethindroneNorethindrone acetate | Apotex Inc | New submission | — |
| Sep 16, 2026 | AmmivoSodium benzoate / Sodium phenylacetate | Sterimax Inc | New substance, priority | — |
| Sep 14, 2026 | Methohexital Sodium For Injection UspMethohexital sodium | Sterimax Inc | New submission | — |
| Sep 4, 2026 | Peridex Oral RinseChlorhexidine gluconate | Solventum Canada Limited | New submission | — |
| Aug 28, 2026 | BosayaDenosumab | Biocon Biologics Canada Inc | New submission | — |
| Aug 28, 2026 | VevzuoDenosumab | Biocon Biologics Canada Inc | New submission | — |
| Aug 24, 2026 | QuinsairLevofloxacin | Chiesi Farmaceutici S.P.A. | New submission | — |
| Aug 18, 2026 | PenthroxMethoxyflurane | Knight Therapeutics Inc. | New submission | — |
| Aug 14, 2026 | FulphilaPegfilgrastim | Biocon Biologics Canada Inc | New submission | — |
| Aug 12, 2026 | Lupin-Sodium CromoglicateCromolyn sodium | Lupin Pharma Canada Limited | New submission | — |
| Aug 12, 2026 | QosequDenosumab | Mantra Pharma Inc. | New submission | — |
| Aug 11, 2026 | Galantamine ErGalantamine hydrobromide | Essential Pharma Switzerland GmbH | New submission | — |
| Aug 10, 2026 | AbevmyBevacizumab | Biocon Biologics Canada Inc | New submission | — |
| Aug 4, 2026 | EtcamahCamizestrant | Astrazeneca Canada Inc | New substance | — |
| Aug 4, 2026 | Pro-Doxylamine-PyridoxineDoxylamine succinate / Pyridoxine hydrochloride | Pro Doc Limitee | New submission | — |
| Jul 29, 2026 | AmbelvistGadoquatrane | Bayer Inc | New substance | — |
| Jul 23, 2026 | AlertecModafinil | Neuraxpharm Pharmaceuticals, S.L. | New submission | — |
| Jul 22, 2026 | SativexCannabidiol / DELTA-9-TETRAHYDROCANNABINOL | Cnx Therapeutics Limited | New submission | — |
| Jul 22, 2026 | Riva-MetforminMetformin hydrochloride | Laboratoire Riva Inc | New submission | — |
| Jul 22, 2026 | FentoraFentanyl citrate | Phoenix Labs Unlimited Company | New submission | — |
| Jul 21, 2026 | Apo-Sumatriptan-Naproxen SodiumNaproxen sodium / Sumatriptan succinate | Apotex Inc | New submission | — |
| Jul 20, 2026 | TryngolzaOlezarsen sodium | Celystra Pharma Inc. | New submission | — |
| Jul 16, 2026 | RhapsidoRemibrutinib | Novartis Pharmaceuticals Canada Inc | New substance | — |
| Jul 13, 2026 | OjemdaTovorafenib | Ipsen Biopharmaceuticals Canada Inc | New substance | With conditions |
| Jul 10, 2026 | OdensifyDenosumab | Jamp Pharma Corporation | New submission | — |
| Jul 10, 2026 | XdenoDenosumab | Jamp Pharma Corporation | New submission | — |
| Jul 10, 2026 | Gabapentin Oral SolutionGabapentin | Rubicon Research Canada Limited | New submission | — |
| Jul 10, 2026 | Nitrolingual PumpsprayNitroglycerin | G. Pohl-Boskamp GmbH & Co Kg | New submission | — |
| Jul 9, 2026 | ScenesseAfamelanotide acetate | Clinuvel, Inc. | New substance | — |
| Jul 8, 2026 | JoenjaLeniolisib phosphate | Pharming Technologies B.V. | New substance, priority | — |
| Jul 2, 2026 | VanrafiaAtrasentan hydrochloride | Novartis Pharmaceuticals Canada Inc | New substance | — |
| Jul 2, 2026 | BesremiRopeginterferon ALFA-2B | Forus Therapeutics Inc | New substance | — |
| Jun 30, 2026 | IdarubicinIdarubicin hcl | Pfizer Canada ULC | New submission | — |
| Jun 30, 2026 | KyzatrexTestosterone undecanoate | Hikma Canada Limited | New submission | — |
| Jun 29, 2026 | RadicavaEdaravone | Shionogi Inc | New submission | — |
| Jun 29, 2026 | CeenuLomustine | Septa Pharmaceuticals Inc | New submission | — |
| Jun 26, 2026 | EdaravoneEdaravone | Shionogi Canada Inc. | New submission | — |
| Jun 26, 2026 | VimkunyaChikungunya virus virus-like particle | Bavarian Nordic As | New substance | — |
| Jun 22, 2026 | BoeyTrenibotulinumtoxine | Abbvie Corporation | New substance | — |
| Jun 17, 2026 | EpysqliEculizumab | Samsung Bioepis Co., Ltd | New submission | — |
| Jun 16, 2026 | HulioAdalimumab | Biocon Biologics Canada Inc | New submission | — |
| Jun 15, 2026 | ExdensurDepemokimab | Glaxosmithkline Inc | New substance | — |
| Jun 12, 2026 | PimjetmiPimicotinib hydrochloride | Emd Serono A Division Of Emd Inc Canada | New substance, priority | — |
| Jun 10, 2026 | Lupin-GlucagonGlucagon | Lupin Pharma Canada Limited | New submission | — |
| Jun 10, 2026 | RanvuRanibizumab | Apotex Inc | New submission | — |
| Jun 9, 2026 | DesferalDeferoxamine mesylate | Mitem Pharma | New submission | — |
| Jun 8, 2026 | Pro-LevocarbCarbidopa / Levodopa | Pro Doc Limitee | New submission | — |
| Jun 8, 2026 | Nra-AtenololAtenolol | Nora Pharma Inc | New submission | — |
| Jun 3, 2026 | IdvynsoDoravirine / Islatravir | Merck Canada Inc | New substance | — |
| May 29, 2026 | LoargysPegzilarginase | Immedica Pharma AB | New substance, priority | — |
| May 29, 2026 | Contingency OneLevonorgestrel | Senador Laboratories Private Limited | New submission | — |
| May 28, 2026 | NorombyEnoxaparin sodium | Juno Pharma Canada Inc. | New submission | — |
| May 22, 2026 | YesafiliAflibercept | Biocon Biologics Canada Inc | New submission | — |
| May 21, 2026 | YesintekUstekinumab | Biocon Biologics Canada Inc | New submission | — |
| May 15, 2026 | ThyconviLevothyroxine sodium | Biosyent Pharma Inc | New submission | — |
| May 14, 2026 | IheezoChloroprocaine hydrochloride | Apotex Inc | New submission | — |
| May 13, 2026 | MuseAlprostadil | Knight Therapeutics Inc. | New submission | — |
| May 12, 2026 | WakixPitolisant hydrochloride | Knight Therapeutics Inc. | New submission | — |
| May 8, 2026 | IncrelexMecasermin | Esteve Pharmaceuticals S.A. | New submission | — |
| May 7, 2026 | KirstyInsulin aspart | Biocon Biologics Canada Inc | New submission | — |
| May 5, 2026 | FrovaFrovatriptan succinate | Knight Therapeutics Inc. | New submission | — |
| May 1, 2026 | XydalbaDalbavancin hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Apr 30, 2026 | KisunlaDonanemab | Eli Lilly Canada Inc | New substance | — |
| Apr 28, 2026 | BevqolvaBevacizumab | Curateq Biologics Private Limited | New submission | — |
| Apr 22, 2026 | BekemvEculizumab | Amgen Canada Inc | New submission | — |
| Apr 22, 2026 | Apo-Diclofenac PowderDiclofenac potassium | Apotex Inc | New submission | — |
| Apr 20, 2026 | VeregenSinecatechins | Knight Therapeutics Inc. | New submission | — |
| Apr 18, 2026 | ConexxenceDenosumab | Fresenius Kabi Canada Ltd | New submission | — |
| Apr 18, 2026 | BomyntraDenosumab | Fresenius Kabi Canada Ltd | New submission | — |
| Apr 17, 2026 | VevzuoDenosumab | Biosimilar Collaborations Ireland Limited | New submission | — |
| Apr 17, 2026 | BosayaDenosumab | Biosimilar Collaborations Ireland Limited | New submission | — |
| Apr 17, 2026 | ReactineCetirizine hydrochloride | Kenvue Canada Inc. | New submission | — |
| Apr 16, 2026 | TevimbraTislelizumab | Beone Medicines I GmbH | New submission | — |
| Apr 13, 2026 | ObodenceDenosumab | Samsung Bioepis Co., Ltd | New submission | — |
| Apr 10, 2026 | Lunsumio ScMosunetuzumab | Hoffmann-La Roche Limited | New submission | With conditions |
| Apr 10, 2026 | UpgolyvGolimumab | Jamp Pharma Corporation | New submission | — |
| Apr 10, 2026 | VuewayGadopiclenol | Bracco Imaging Canada | New substance | — |
| Apr 9, 2026 | NeffyEpinephrine | Alk- Abello A/S | New submission | — |
| Apr 9, 2026 | YeytuoLenacapavir sodium | Gilead Sciences Canada Inc | New submission | — |
| Apr 9, 2026 | Atenolol TabletsAtenolol | Sanis Health Inc | New submission | — |
| Apr 8, 2026 | AntizolFomepizole | Knight Therapeutics Inc. | New submission | — |
| Apr 1, 2026 | MonurolFosfomycin | Knight Therapeutics Inc. | New submission | — |
| Mar 31, 2026 | CamceviLeuprolide mesylate | Accord Healthcare Inc | New submission | — |
| Mar 30, 2026 | XbrykDenosumab | Samsung Bioepis Co., Ltd | New submission | — |
| Mar 26, 2026 | SpevigoSpesolimab | Leo Pharma Inc | New submission | — |
| Mar 26, 2026 | CtpCitalopram | Knight Therapeutics Inc. | New submission | — |
| Mar 24, 2026 | FlorinefFludrocortisone 21-ACETATE | Knight Therapeutics Inc. | New submission | — |
| Mar 23, 2026 | Envarsus PaTacrolimus | Knight Therapeutics Inc. | New submission | — |
| Mar 23, 2026 | DenozaDenosumab | Apotex Inc | New submission | — |
| Mar 20, 2026 | MetadolMethadone hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Mar 20, 2026 | Act CitalopramCitalopram | Knight Therapeutics Inc. | New submission | — |
| Mar 18, 2026 | Odan-Aripiprazole SolutionAripiprazole | Odan Laboratories Ltd | New submission | — |
| Mar 16, 2026 | AdstiladrinNadofaragene firadenovec | Ferring Inc | New substance | — |
| Mar 13, 2026 | ClobivisClobetasol propionate | Apotex Inc | New submission | — |
| Mar 12, 2026 | Zimed PfBimatoprost | Luvo Medical Technologies Inc | New submission | — |
| Mar 12, 2026 | ReactineCetirizine hydrochloride | Kenvue Canada Inc. | New submission | — |
| Mar 12, 2026 | Reactine CompleteCetirizine hydrochloride / Pseudoephedrine hcl | Kenvue Canada Inc. | New submission | — |
| Mar 12, 2026 | Imodium Liqui-GelsLoperamide hcl | Kenvue Canada Inc. | New submission | — |
| Mar 11, 2026 | IdenosDenosumab | Apotex Inc | New submission | — |
| Mar 9, 2026 | TuzemtyDenosumab | Shanghai Henlius Biotech, Inc. | New submission | — |
| Mar 9, 2026 | BildyosDenosumab | Shanghai Henlius Biotech, Inc. | New submission | — |
| Mar 9, 2026 | Rhinocort AquaBudesonide | Kenvue Canada Inc. | New submission | — |
| Mar 9, 2026 | TriduralTramadol hcl | Knight Therapeutics Inc. | New submission | — |
| Mar 6, 2026 | NuvaxovidSARS-COV-2 recombinant spike protein (omicron XBB.1.5) | Sanofi Vaccines Canada Ltd. | New submission | — |
| Mar 6, 2026 | CysklarCysteamine hydrochloride | Leadiant Biosciences, Inc. | New submission | — |
| Mar 6, 2026 | Nucynta IrTapentadol hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Mar 6, 2026 | RadicavaEdaravone | Tanabe Pharma Corporation | New submission | — |
| Mar 5, 2026 | Nucynta Extended-ReleaseTapentadol hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Mar 5, 2026 | Metadol-DMethadone hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Mar 4, 2026 | BalansyaEscitalopram oxalate | Orimed Pharma Inc | New submission | — |
| Mar 1, 2026 | MotrinIbuprofen | Kenvue Canada Inc. | New submission | — |
| Feb 26, 2026 | Extra Strength Tylenol NighttimeAcetaminophen / Diphenhydramine hcl | Kenvue Canada Inc. | New submission | — |
| Feb 26, 2026 | Advil Cold & Sinus Convenience PackChlorpheniramine maleate / Ibuprofen / Pseudoephedrine hcl | Haleon Canada ULC | New submission | — |
| Feb 25, 2026 | Mint-Citalopram SolutionCitalopram hydrobromide | Mint Pharmaceuticals Inc | New submission | — |
| Feb 25, 2026 | DexedrineDextroamphetamine sulfate | Knight Therapeutics Inc. | New submission | — |
| Feb 13, 2026 | AdruxeRituximab | Dr. Reddy'S Laboratories SA | New submission | — |
| Feb 12, 2026 | Rifapentine TabletsRifapentine | Macleods Pharmaceuticals Limited | New substance | — |
| Feb 11, 2026 | Infants' MotrinIbuprofen | Kenvue Canada Inc. | New submission | — |
| Feb 10, 2026 | Pregabalin Oral SolutionPregabalin | Orb Pharma- Division Of Odan Laboratories Ltd. | New submission | — |
| Feb 6, 2026 | LunsumioMosunetuzumab | Hoffmann-La Roche Limited | New substance | With conditions |
| Feb 4, 2026 | CyclobenzaprineCyclobenzaprine hydrochloride | Sanis Health Inc | New submission | — |
| Feb 2, 2026 | TrinipatchNitroglycerin | Knight Therapeutics Inc. | New submission | — |
| Feb 2, 2026 | Advil Back PainIbuprofen / Methocarbamol | Haleon Canada ULC | New submission | — |
| Jan 30, 2026 | EnflonsiaClesrovimab | Merck Canada Inc | New substance | — |
| Jan 30, 2026 | RecarbrioCilastatin sodium / Imipenem / Relebactam | Merck Canada Inc | New substance, priority | — |
| Jan 29, 2026 | HyrnuoSevabertinib | Bayer Inc | New substance | With conditions |
| Jan 28, 2026 | YorvipathPalopegteriparatide | Pendopharm Division Of Pharmascience Inc | New substance | — |
| Jan 27, 2026 | Dantrium CapsulesDantrolene sodium | Knight Therapeutics Inc. | New submission | — |
| Jan 22, 2026 | SilenorDoxepin hcl | Knight Therapeutics Inc. | New submission | — |
| Jan 21, 2026 | VoxzogoVosoritide | Biomarin International Limited | New substance | With conditions |
| Jan 20, 2026 | LunestaEszopiclone | Knight Therapeutics Inc. | New submission | — |
| Jan 16, 2026 | TestimTestosterone | Knight Therapeutics Inc. | New submission | — |
| Jan 16, 2026 | Dantrium IntravenousDantrolene sodium | Knight Therapeutics Inc. | New submission | — |
| Jan 15, 2026 | ZiiheraZanidatamab | Jazz Pharmaceuticals Ireland Limited | New substance | With conditions |
| Jan 12, 2026 | ImuldosaUstekinumab | Accord Healthcare Inc | New submission | — |
| Jan 9, 2026 | Apo-Naproxen / EsomeprazoleEsomeprazole / Naproxen | Apotex Inc | New submission | — |
| Jan 6, 2026 | DyrupegPegfilgrastim | Curateq Biologics Private Limited | New submission | — |
| Jan 2, 2026 | RedemploPlozasiran | Arrowhead Pharmaceuticals, Inc. | New substance, priority | — |
| Jan 2, 2026 | Pms-Metronidazole GelMetronidazole | Pharmascience Inc | New submission | — |
| Dec 29, 2025 | TrandateLabetalol hcl | Knight Therapeutics Inc. | New submission | — |
| Dec 24, 2025 | Men'S RogaineMinoxidil | Kenvue Canada Inc. | New submission | — |
| Dec 23, 2025 | JeraygoAprocitentan | Idorsia Pharmaceuticals Ltd | New substance | — |
| Dec 23, 2025 | Locacorten Vioform EardropsClioquinol / Flumethasone pivalate | Knight Therapeutics Inc. | New submission | — |
| Dec 22, 2025 | PlosbrioSemaglutide | Novo Nordisk Canada Inc | New submission | — |
| Dec 22, 2025 | PoviztraSemaglutide | Novo Nordisk Canada Inc | New submission | — |
| Dec 19, 2025 | Locacorten VioformClioquinol / Flumethasone pivalate | Knight Therapeutics Inc. | New submission | — |
| Dec 19, 2025 | TapazoleMethimazole | Knight Therapeutics Inc. | New submission | — |
| Dec 19, 2025 | XcopriCenobamate | Knight Therapeutics Inc. | New submission | — |
| Dec 18, 2025 | NemluvioNemolizumab | Galderma Canada Inc | New substance | — |
| Dec 18, 2025 | TevimbraTislelizumab | Beone Medicines I GmbH | New substance | — |
| Dec 18, 2025 | Pepcid CompleteCalcium carbonate / Famotidine / Magnesium hydroxide | Kenvue Canada Inc. | New submission | — |
| Dec 16, 2025 | TryngolzaOlezarsen sodium | Theratechnologies Inc | New substance, priority | — |
| Dec 12, 2025 | Jatenzo (Testosterone Undecanoate)Testosterone undecanoate | Tolmar International Ltd. | New submission | — |
| Dec 9, 2025 | ElfabrioPegunigalsidase alfa | Chiesi Farmaceutici S.P.A. | New substance | — |
| Dec 5, 2025 | ImaavyNipocalimab | Janssen Inc | New substance | — |
| Dec 5, 2025 | Septra Pediatric Oral SuspensionSulfamethoxazole / Trimethoprim | Aspen Pharmacare Canada Inc. | New submission | — |
| Dec 5, 2025 | ZurzuvaeZuranolone | Biogen Canada Inc | New substance | — |
| Dec 4, 2025 | TwyneoBenzoyl peroxide / Tretinoin | Searchlight Pharma Inc | New submission | — |
| Dec 2, 2025 | Lataneo PfLatanoprost | Orimed Pharma Inc | New submission | — |
| Nov 28, 2025 | Sandomigran DsPizotifen malate | Knight Therapeutics Inc. | New submission | — |
| Nov 28, 2025 | Pepcid AcFamotidine | Kenvue Canada Inc. | New submission | — |
| Nov 28, 2025 | Imodium CompleteLoperamide hcl / Simethicone | Kenvue Canada Inc. | New submission | — |
| Nov 25, 2025 | AddyiFlibanserin | Sprout Pharmaceuticals Inc | New submission | — |
| Nov 25, 2025 | Alog-PropiverinePropiverine hydrochloride | Analog Pharma Canada Inc. | New submission | — |
| Nov 24, 2025 | EydenzeltAflibercept | Celltrion Inc | New submission | — |
| Nov 24, 2025 | BrukinsaZanubrutinib | Beone Medicines I GmbH | New submission | — |
| Nov 24, 2025 | TukysaTucatinib | Pfizer Canada ULC | New submission | — |
| Nov 21, 2025 | WynzoraBetamethasone dipropionate / Calcipotriol | Knight Therapeutics Inc. | New submission | — |
| Nov 21, 2025 | PennsaidDiclofenac sodium | Knight Therapeutics Inc. | New submission | — |
| Nov 21, 2025 | Advil Headache & Migraine CapletsIbuprofen sodium dihydrate | Haleon Canada ULC | New submission | — |
| Nov 19, 2025 | AhzantiveAflibercept | Valorum Biologics LLC | New submission | — |
| Nov 14, 2025 | NilemdoBempedoic acid | Hls Therapeutics Inc | New substance | — |
| Nov 10, 2025 | KyzatrexTestosterone undecanoate | Marius Pharmaceuticals, LLC | New submission | — |
| Nov 7, 2025 | ClasteonClodronate disodium | Knight Therapeutics Inc. | New submission | — |
| Nov 6, 2025 | RetevmoSelpercatinib | Eli Lilly Canada Inc | New submission | With conditions |
| Nov 5, 2025 | OrgovyxRelugolix | Knight Therapeutics Inc. | New submission | — |
| Oct 31, 2025 | CombogesicAcetaminophen / Ibuprofen | Aft Pharmaceuticals (Can) Limited | New submission | — |
| Oct 30, 2025 | EnzeevuAflibercept | Sandoz Canada Incorporated | New submission | — |
| Oct 28, 2025 | Doxycycline For Injection UspDoxycycline hyclate | Sterimax Inc | New submission | — |
| Oct 28, 2025 | MyfembreeEstradiol / Norethindrone acetate / Relugolix | Knight Therapeutics Inc. | New submission | — |
| Oct 24, 2025 | LeqembiLecanemab | Eisai Limited | New substance | With conditions |
| Oct 17, 2025 | YesintekUstekinumab | Biosimilar Collaborations Ireland Limited | New submission | — |
| Oct 17, 2025 | LoqtorziToripalimab | Apotex Inc | New substance | — |
| Oct 17, 2025 | JaypircaPirtobrutinib | Eli Lilly Canada Inc | New substance | With conditions |
| Oct 17, 2025 | NitrojectNitroglycerin | Juno Pharma Canada Inc. | New submission | — |
| Oct 16, 2025 | AvtozmaTocilizumab | Celltrion Inc | New submission | — |
| Oct 16, 2025 | LyvdelziSeladelpar lysine | Gilead Sciences Canada Inc | New substance | With conditions |
| Oct 14, 2025 | Aa-VerapVerapamil hcl | Aa Pharma Inc | New submission | — |
| Oct 14, 2025 | Articaine Hydrochloride And Epinephrine Injection - NArticaine hcl / Epinephrine bitartrate | Septodont | New submission | — |
| Oct 9, 2025 | OpuvizAflibercept | Samsung Bioepis Co., Ltd | New submission | — |
| Oct 9, 2025 | AdcetrisBrentuximab vedotin | Pfizer Canada ULC | New submission | — |
| Oct 7, 2025 | SephienceSepiapterin | Ptc Therapeutics International Limited | New substance, priority | — |
| Oct 1, 2025 | Lupin-RifaximinRifaximin | Lupin Pharma Canada Limited | New submission | — |
| Sep 29, 2025 | MnexspikeSARSCOV2 s-protein ntd-rbd subdomains mrna, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | Moderna Biopharma Canada Corporation | New substance | — |
| Sep 29, 2025 | AgamreeVamorolone | Kye Pharmaceuticals Inc | New substance, priority | — |
| Sep 26, 2025 | Advil Cold And SinusIbuprofen / Pseudoephedrine hcl | Haleon Canada ULC | New submission | — |
| Sep 24, 2025 | TyrukoNatalizumab | Polpharma Biologics S.A. | New submission | — |
| Sep 19, 2025 | PadcevEnfortumab vedotin | Pfizer Canada ULC | New submission | — |
| Sep 17, 2025 | OsenveltDenosumab | Celltrion Inc | New submission | — |
| Sep 17, 2025 | StobocloDenosumab | Celltrion Inc | New submission | — |
| Sep 15, 2025 | Pro-AtenololAtenolol | Pro Doc Limitee | New submission | — |
| Sep 12, 2025 | OritinivOritavancin phosphate | Xediton Pharmaceuticals Inc | New substance, priority | — |
| Sep 10, 2025 | Jamp Aripiprazole Oral SolutionAripiprazole | Jamp Pharma Corporation | New submission | — |
| Sep 8, 2025 | SlenytoMelatonin | Neurim Pharmaceuticals Ltd. | New submission | — |
| Sep 5, 2025 | AccutaneIsotretinoin | Cheplapharm Schweiz GmbH | New submission | — |
| Sep 3, 2025 | NduvraTapinarof | Organon Canada Inc. | New submission | — |
| Aug 29, 2025 | ElahereMirvetuximab soravtansine | Abbvie Corporation | New substance, priority | — |
| Aug 28, 2025 | Advil NighttimeDiphenhydramine hcl / Ibuprofen | Haleon Canada ULC | New submission | — |
| Aug 28, 2025 | Robax PlatinumIbuprofen / Methocarbamol | Haleon Canada ULC | New submission | — |
| Aug 27, 2025 | EpsolayBenzoyl peroxide | Searchlight Pharma Inc | New submission | — |
| Aug 27, 2025 | Apo-DoxepinDoxepin hcl | Apotex Inc | New submission | — |
| Aug 25, 2025 | PonvoryPonesimod | Vanda Pharmaceuticals Inc | New submission | — |
| Aug 25, 2025 | AnzupgoDelgocitinib | Leo Pharma Inc | New substance | — |
| Aug 25, 2025 | Sandoz Sacubitril-ValsartanSacubitril / Valsartan | Sandoz Canada Incorporated | New submission | — |
| Aug 21, 2025 | Children'S AdvilIbuprofen | Haleon Canada ULC | New submission | — |
| Aug 19, 2025 | Odan-PregabalinPregabalin | Odan Laboratories Ltd | New submission | — |
| Aug 18, 2025 | NimotopNimodipine | Laboratoire X.0 | New submission | — |
| Aug 15, 2025 | AmtagviLifileucel | Iovance Biotherapeutics, Inc | New substance | With conditions |
| Aug 14, 2025 | Advil Liqui-GelsIbuprofen | Haleon Canada ULC | New submission | — |
| Aug 8, 2025 | HepcludexBulevirtide acetate | Gilead Sciences Canada Inc | New substance, priority | — |
| Aug 6, 2025 | AndembryGaradacimab | Csl Behring Canada Inc | New substance | — |
| Aug 5, 2025 | Cyclophosphamide For InjectionCyclophosphamide | Dr Reddys Laboratories Ltd | New submission | — |
| Jul 28, 2025 | Dyanavel XrAmphetamine / Amphetamine aspartate monohydrate / Mixed salts amphetamine | Kye Pharmaceuticals Inc | New submission | — |
| Jul 23, 2025 | LynkuetElinzanetant | Bayer Inc | New substance | — |
| Jul 22, 2025 | BuccolamMidazolam hydrochloride | Neuraxpharm Pharmaceuticals, S.L. | New submission | — |
| Jul 21, 2025 | BlenrepBelantamab mafodotin | Glaxosmithkline Inc | New submission | — |
| Jul 21, 2025 | AlyftrekDeutivacaftor / Tezacaftor / Vanzacaftor calcium | Vertex Pharmaceuticals (Canada) Incorporated | New substance | — |
| Jul 18, 2025 | BlenrepBelantamab mafodotin | Glaxosmithkline Inc | New substance | — |
| Jul 17, 2025 | LivmotyGolimumab | Janssen Inc | New submission | — |
| Jul 14, 2025 | XipereTriamcinolone acetonide | Bausch & Lomb Inc | New submission | — |
| Jul 9, 2025 | ProleukinAldesleukin | Iovance Biotherapeutics Manufacturing LLC | New submission | — |
| Jul 8, 2025 | PavbluAflibercept | Amgen Canada Inc | New submission | — |
| Jul 4, 2025 | Amivas-ArtesunateArtesunate | Amivas Ireland Ltd. | New substance, priority | — |
| Jul 3, 2025 | IsturisaOsilodrostat phosphate | Recordati Rare Diseases Canada Inc | New substance | — |
| Jun 26, 2025 | AflivuAflibercept | Apotex Inc | New submission | — |
| Jun 26, 2025 | YesafiliAflibercept | Biosimilar Collaborations Ireland Limited | New submission | — |
| Jun 26, 2025 | LysodrenMitotane | Esteve Pharmaceuticals S.A. | New submission | — |
| Jun 25, 2025 | AnaproxNaproxen sodium | Searchlight Pharma Inc | New submission | — |
| Jun 24, 2025 | Apo-Pentoxifylline SrPentoxifylline | Apotex Inc | New submission | — |
| Jun 19, 2025 | Nb-Bisoprolol TabletsBisoprolol fumarate | Nb Pharma Inc. | New submission | — |
| Jun 18, 2025 | LongavoRisperidone | Teva Canada Limited | New submission | — |
| Jun 11, 2025 | NexiumEsomeprazole magnesium trihydrate | Haleon Canada ULC | New submission | — |
| Jun 11, 2025 | Surface Cleaner Sanitizer WipesLactic acid / Linear dodecyl benzene sulfonic acid | Ecolab Co | New submission | — |
| Jun 9, 2025 | VanflytaQuizartinib hydrochloride | Daiichi Sankyo Pharma Canada Limited | New substance | — |
| Jun 4, 2025 | PiaskyCrovalimab | Hoffmann-La Roche Limited | New substance | — |
| May 30, 2025 | PennsaidDiclofenac sodium | Endo Operations Ltd. | New submission | — |
| May 23, 2025 | TrandateLabetalol hcl | Endo Operations Ltd. | New submission | — |
| May 22, 2025 | AdvilIbuprofen | Haleon Canada ULC | New submission | — |
| May 16, 2025 | Advil Cold & Sinus PlusChlorpheniramine maleate / Ibuprofen / Pseudoephedrine hcl | Haleon Canada ULC | New submission | — |
| May 16, 2025 | Sterilex Ultra-Kleen SolutionAlkyl dimethyl ethylbenzyl ammonium chloride / Dimethylbenzyl ammonium chloride /… | Sterilex LLC Dba Sterilex | New submission | — |
| May 16, 2025 | TrimbowBeclomethasone dipropionate / Formoterol fumarate dihydrate / Glycopyrronium bromide | Chiesi Farmaceutici S.P.A. | New submission | — |
| May 16, 2025 | Pms-MethadoneMethadone hydrochloride | Endo Operations Ltd. | New submission | — |
| May 13, 2025 | Zepbound KwikpenTirzepatide | Eli Lilly Canada Inc | New submission | — |
| May 9, 2025 | MuseAlprostadil | Endo Operations Ltd. | New submission | — |
| May 8, 2025 | AndrocurCyproterone acetate | Amdipharm Limited | New submission | — |
| May 7, 2025 | AugtyroRepotrectinib | Bristol-Myers Squibb Canada | New substance | — |
| May 5, 2025 | TzieldTeplizumab | Sanofi-Aventis Canada Inc | New substance, priority | — |
| May 1, 2025 | Locacorten Vioform EardropsClioquinol / Flumethasone pivalate | Endo Operations Ltd. | New submission | — |
| May 1, 2025 | Pms-IvermectinIvermectin | Pharmascience Inc | New submission | — |
| Apr 28, 2025 | Advil Liqui-GelsIbuprofen | Haleon Canada ULC | New submission | — |
| Apr 25, 2025 | IqirvoElafibranor | Ipsen Biopharmaceuticals Canada Inc | New substance | With conditions |
| Apr 25, 2025 | RystiggoRozanolixizumab | Ucb Canada Inc | New substance | — |
| Apr 24, 2025 | NaprosynNaproxen | Searchlight Pharma Inc | New submission | — |
| Apr 24, 2025 | Labetalol Hydrochloride Injection InLabetalol hcl | Hikma Canada Limited | New submission | — |
| Apr 17, 2025 | TepezzaTeprotumumab | Amgen Canada Inc | New substance | — |
| Apr 17, 2025 | ProcysbiCysteamine bitartrate | Amgen Canada Inc | New submission | — |
| Apr 15, 2025 | Metadol-DMethadone hydrochloride | Endo Operations Ltd. | New submission | — |
| Apr 14, 2025 | PombilitiCipaglucosidase alfa | Amicus Therapeutics Canada Inc. | New substance | — |
| Apr 10, 2025 | OpfoldaMiglustat | Amicus Therapeutics Canada Inc. | New submission | — |
| Apr 9, 2025 | ElyxybCelecoxib | Scilex Pharmaceuticals Inc. | New submission | — |
| Apr 8, 2025 | DipentumOlsalazine sodium | Searchlight Pharma Inc | New submission | — |
| Apr 4, 2025 | NduvraTapinarof | Dermavant Sciences GmbH | New substance | — |
| Mar 31, 2025 | UpliznaInebilizumab | Amgen Canada Inc | New submission | — |
| Mar 26, 2025 | AltuviiioAntihemophilic factor viii (recombinant, bdd), fc-vwf-xten fusion protein | Sanofi-Aventis Canada Inc | New substance | — |
| Mar 24, 2025 | FilraFilgrastim (r-methug-csf) | Jamp Pharma Corporation | New submission | — |
| Mar 21, 2025 | KavigaleSipavibart | Astrazeneca Canada Inc | New substance | — |
| Mar 20, 2025 | XfusorRopivacaine hydrochloride | Formative Pharma Inc. | New submission | — |
| Mar 20, 2025 | MycamineMicafungin sodium | Sandoz Canada Incorporated | New submission | — |
| Mar 19, 2025 | Seroquel XrQuetiapine fumarate | Cheplapharm Arzneimittel GmbH | New submission | — |
| Mar 18, 2025 | SeroquelQuetiapine fumarate | Cheplapharm Arzneimittel GmbH | New submission | — |
| Mar 18, 2025 | MetadolMethadone hydrochloride | Endo Operations Ltd. | New submission | — |
| Mar 13, 2025 | SkyclarysOmaveloxolone | Biogen Canada Inc | New substance, priority | — |
| Mar 7, 2025 | TapazoleMethimazole | Endo Operations Ltd. | New submission | — |
| Mar 7, 2025 | ZynlontaLoncastuximab tesirine | Swedish Orphan Biovitrum AB (Publ) | New substance | With conditions |
| Mar 6, 2025 | LazcluzeLazertinib mesylate | Janssen Inc | New substance | — |
| Mar 5, 2025 | RebyotaFecal microbiota | Ferring Inc | New substance | — |
| Mar 5, 2025 | Sandomigran DsPizotifen malate | Endo Operations Ltd. | New submission | — |
| Mar 5, 2025 | NalcromCromolyn sodium | Lupin Pharma Canada Limited | New submission | — |
| Feb 28, 2025 | QalsodyTofersen | Biogen Canada Inc | New substance | With conditions |
| Feb 27, 2025 | Pms-DoxycyclineDoxycycline | Pharmascience Inc | New submission | — |
| Feb 27, 2025 | SilenorDoxepin hcl | Endo Operations Ltd. | New submission | — |
| Feb 19, 2025 | TriduralTramadol hcl | Endo Operations Ltd. | New submission | — |
| Feb 14, 2025 | Locacorten VioformClioquinol / Flumethasone pivalate | Endo Operations Ltd. | New submission | — |
| Feb 14, 2025 | ItovebiInavolisib | Hoffmann-La Roche Limited | New substance, priority | — |
| Feb 13, 2025 | FamvirFamciclovir | Searchlight Pharma Inc | New submission | — |
| Feb 12, 2025 | KloxxadoNaloxone hydrochloride | Hikma Canada Limited | New submission | — |
| Feb 6, 2025 | ZynyzRetifanlimab | Incyte Corporation | New substance | — |
| Jan 30, 2025 | ZyprexaOlanzapine / Olanzapine tartrate | Cheplapharm Registration GmbH | New submission | — |
| Jan 30, 2025 | Jornay PmMethylphenidate hydrochloride | Knight Therapeutics Inc. | New submission | — |
| Jan 29, 2025 | Voltaren EmulgelDiclofenac diethylamine | Haleon Canada ULC | New submission | — |
| Jan 22, 2025 | Combogesic IvAcetaminophen / Ibuprofen | Aft Pharmaceuticals (Can) Limited | New submission | — |
| Jan 20, 2025 | Levulan KerastickAminolevulinic acid hydrochloride | Sun Pharmaceutical Industries, Inc. | New submission | — |
| Jan 17, 2025 | BaxdelaDelafloxacin meglumine | Xediton Pharmaceuticals Inc | New substance, priority | — |
| Jan 15, 2025 | Aripiprazole Oral SolutionAripiprazole | Orimed Pharma Inc | New submission | — |
| Jan 6, 2025 | FabhaltaIptacopan hydrochloride | Novartis Pharmaceuticals Canada Inc | New substance | — |
| Dec 31, 2024 | FlorinefFludrocortisone 21-ACETATE | Endo Operations Ltd. | New submission | — |
| Dec 30, 2024 | OtulfiUstekinumab | Fresenius Kabi Canada Ltd | New submission | — |
| Dec 24, 2024 | Bisoprolol TabletsBisoprolol fumarate | Sivem Pharmaceuticals ULC | New submission | — |
| Dec 20, 2024 | VabomereMeropenem trihydrate / Vaborbactam | Xediton Pharmaceuticals Inc | New substance, priority | — |
| Dec 18, 2024 | RingzaEthinyl estradiol / Segesterone acetate | Duchesnay Inc | New substance | — |
| Dec 17, 2024 | SativexCannabidiol / DELTA-9-TETRAHYDROCANNABINOL | Jazz Pharmaceuticals Operations Uk Limited | New submission | — |
| Dec 13, 2024 | PexegraPegfilgrastim | Jamp Pharma Corporation | New submission | — |
| Dec 13, 2024 | VyloyZolbetuximab | Astellas Pharma Canada Inc | New substance | — |
| Dec 6, 2024 | OmlycloOmalizumab | Celltrion Inc | New submission | — |
| Dec 3, 2024 | FlucelvaxHaemagglutinin-strain A(H1N1) / Haemagglutinin-strain A(H3N2) / Haemagglutinin-strain… | Seqirus Uk Limited | New submission | — |
| Dec 2, 2024 | VeozahFezolinetant | Astellas Pharma Canada Inc | New substance | — |
Every New Active Substance Since 1994
With the first US approval of the same ingredient in Drugs@FDA. Sort by the gap to find the longest waits.| Nov 13, 2026 | FoundayoOrforglipron calcium | Eli Lilly Canada Inc | StandardNotice | Apr 1, 2026 | 7 mo later |
| Nov 10, 2026 | InpefaSotagliflozin | Bgp Pharma ULC | StandardNotice | May 26, 2023 | 42 mo later |
| Nov 10, 2026 | InluriyoImlunestrant tosylate | Eli Lilly Canada Inc | StandardNotice | Sep 25, 2025 | 14 mo later |
| Nov 4, 2026 | McofluInfluenza A/H1N1 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza A/H3N2 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza b/victoria mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / SARSCOV2 s-protein ntd-rbd subdomains mrna, 5'(M7G-5'-PPP-5'-GM), 3'POLYA | Moderna Biopharma Canada Corporation | StandardNotice | No US match | — |
| Nov 4, 2026 | MflusivaInfluenza A/H1N1 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza A/H3N2 mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail / Influenza b/victoria mrna, 5'(M7G-5'-PPP-5'-GM) cap, 3' poly(a) tail | Moderna Biopharma Canada Corporation | StandardNotice | No US match | — |
| Oct 30, 2026 | HibsagoBepirovirsen sodium | Glaxosmithkline Inc | PriorityNotice | Oct 20, 2026 | Same month |
| Oct 14, 2026 | MyqorzoAficamten | Cytokinetics, Incorporated | StandardNotice | Dec 19, 2025 | 10 mo later |
| Oct 8, 2026 | JascaydNerandomilast | Boehringer Ingelheim (Canada) Ltd Ltee | StandardNotice | Oct 7, 2025 | 12 mo later |
| Oct 2, 2026 | FrehemgoDenecimig | Novo Nordisk Canada Inc | StandardNotice | No US match | — |
| Sep 28, 2026 | DawnzeraDonidalorsen sodium | Celystra Pharma Inc. | StandardNotice | Aug 21, 2025 | 13 mo later |
| Sep 24, 2026 | Prostalumin(18F)PSMA-1007 | Centre For Probe Development And Commercialization | StandardNotice | No US match | — |
| Sep 24, 2026 | HernexeosZongertinib | Boehringer Ingelheim (Canada) Ltd Ltee | StandardNotice | Aug 8, 2025 | 14 mo later |
| Sep 16, 2026 | AmmivoSodium benzoate / Sodium phenylacetate | Sterimax Inc | PriorityNotice | No US match | — |
| Aug 4, 2026 | EtcamahCamizestrant | Astrazeneca Canada Inc | StandardNotice | Sep 4, 2026 | 1 mo earlier |
| Jul 29, 2026 | AmbelvistGadoquatrane | Bayer Inc | StandardNotice | Jun 12, 2026 | 2 mo later |
| Jul 16, 2026 | RhapsidoRemibrutinib | Novartis Pharmaceuticals Canada Inc | StandardNotice | Sep 30, 2025 | 9 mo later |
| Jul 13, 2026 | OjemdaTovorafenib | Ipsen Biopharmaceuticals Canada Inc | StandardNotice | Apr 23, 2024 | 27 mo later |
| Jul 9, 2026 | ScenesseAfamelanotide acetate | Clinuvel, Inc. | StandardNotice | Oct 8, 2019 | 81 mo later |
| Jul 8, 2026 | JoenjaLeniolisib phosphate | Pharming Technologies B.V. | PriorityNotice | Mar 24, 2023 | 39 mo later |
| Jul 2, 2026 | VanrafiaAtrasentan hydrochloride | Novartis Pharmaceuticals Canada Inc | StandardNotice | Apr 2, 2025 | 15 mo later |
| Jul 2, 2026 | BesremiRopeginterferon ALFA-2B | Forus Therapeutics Inc | StandardNotice | Nov 12, 2021 | 56 mo later |
| Jun 26, 2026 | VimkunyaChikungunya virus virus-like particle | Bavarian Nordic As | StandardNotice | No US match | — |
| Jun 22, 2026 | BoeyTrenibotulinumtoxine | Abbvie Corporation | StandardNotice | No US match | — |
| Jun 15, 2026 | ExdensurDepemokimab | Glaxosmithkline Inc | StandardNotice | Dec 16, 2025 | 6 mo later |
| Jun 12, 2026 | PimjetmiPimicotinib hydrochloride | Emd Serono A Division Of Emd Inc Canada | PriorityNotice | No US match | — |
| Jun 3, 2026 | IdvynsoDoravirine / Islatravir | Merck Canada Inc | StandardNotice | No US match | — |
| May 29, 2026 | LoargysPegzilarginase | Immedica Pharma AB | PriorityNotice | Feb 23, 2026 | 3 mo later |
| Apr 30, 2026 | KisunlaDonanemab | Eli Lilly Canada Inc | StandardNotice | Jul 2, 2024 | 22 mo later |
| Apr 10, 2026 | VuewayGadopiclenol | Bracco Imaging Canada | StandardNotice | Sep 21, 2022 | 43 mo later |
| Mar 16, 2026 | AdstiladrinNadofaragene firadenovec | Ferring Inc | StandardNotice | Dec 16, 2022 | 39 mo later |
| Feb 12, 2026 | Rifapentine TabletsRifapentine | Macleods Pharmaceuticals Limited | StandardNotice | Jun 22, 1998 | 332 mo later |
| Feb 6, 2026 | LunsumioMosunetuzumab | Hoffmann-La Roche Limited | StandardNotice | Dec 22, 2022 | 38 mo later |
| Jan 30, 2026 | EnflonsiaClesrovimab | Merck Canada Inc | StandardNotice | Jun 9, 2025 | 8 mo later |
| Jan 30, 2026 | RecarbrioCilastatin sodium / Imipenem / Relebactam | Merck Canada Inc | PriorityNotice | No US match | — |
| Jan 29, 2026 | HyrnuoSevabertinib | Bayer Inc | StandardNotice | Nov 19, 2025 | 2 mo later |
| Jan 28, 2026 | YorvipathPalopegteriparatide | Pendopharm Division Of Pharmascience Inc | StandardNotice | Aug 9, 2024 | 18 mo later |
| Jan 21, 2026 | VoxzogoVosoritide | Biomarin International Limited | StandardNotice | Nov 19, 2021 | 50 mo later |
| Jan 15, 2026 | ZiiheraZanidatamab | Jazz Pharmaceuticals Ireland Limited | StandardNotice | Nov 20, 2024 | 14 mo later |
| Jan 2, 2026 | RedemploPlozasiran | Arrowhead Pharmaceuticals, Inc. | PriorityNotice | Nov 18, 2025 | 1 mo later |
| Dec 23, 2025 | JeraygoAprocitentan | Idorsia Pharmaceuticals Ltd | StandardNotice | Mar 19, 2024 | 21 mo later |
| Dec 18, 2025 | NemluvioNemolizumab | Galderma Canada Inc | StandardNotice | Aug 12, 2024 | 16 mo later |
| Dec 18, 2025 | TevimbraTislelizumab | Beone Medicines I GmbH | StandardNotice | Mar 13, 2024 | 21 mo later |
| Dec 16, 2025 | TryngolzaOlezarsen sodium | Theratechnologies Inc | PriorityNotice | Dec 19, 2024 | 12 mo later |
| Dec 9, 2025 | ElfabrioPegunigalsidase alfa | Chiesi Farmaceutici S.P.A. | StandardNotice | May 9, 2023 | 31 mo later |
| Dec 5, 2025 | ImaavyNipocalimab | Janssen Inc | StandardNotice | Apr 29, 2025 | 7 mo later |
| Dec 5, 2025 | ZurzuvaeZuranolone | Biogen Canada Inc | StandardNotice | Aug 4, 2023 | 28 mo later |
| Nov 14, 2025 | NilemdoBempedoic acid | Hls Therapeutics Inc | StandardNotice | Feb 21, 2020 | 69 mo later |
| Oct 24, 2025 | LeqembiLecanemab | Eisai Limited | StandardNotice | Jan 6, 2023 | 34 mo later |
| Oct 17, 2025 | LoqtorziToripalimab | Apotex Inc | StandardNotice | Oct 27, 2023 | 24 mo later |
| Oct 17, 2025 | JaypircaPirtobrutinib | Eli Lilly Canada Inc | StandardNotice | Jan 27, 2023 | 33 mo later |
A Notice of Compliance is Health Canada's approval. These are original New Drug Submissions for human drugs; supplements, generics (abbreviated submissions) and veterinary drugs are left out. A new active substance is Health Canada's own submission class. The US match is by ingredient name, ignoring salts; combinations, vaccines and products named differently in each country show no US match. Refreshed weekly. Health Canada, Notice of Compliance database; FDA Drugs@FDA